USA Financial Formulas’s Timken Company TKR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$185K Sell
1,276
-599
-32% -$72K 0.03% 144
2026
Q1
$189K Buy
+1,875
New +$186K 0.04% 119
2023
Q4
Sell
-930
Closed -$68.3K 537
2023
Q3
$68.3K Hold
930
0.1% 189
2023
Q2
$85.1K Sell
930
-506
-35% -$39.9K 0.13% 120
2023
Q1
$117K Buy
+1,436
New +$116K 0.19% 80
2021
Q3
Sell
-3,087
Closed -$249K 479
2021
Q2
$249K Sell
3,087
-303
-9% -$25.6K 0.21% 123
2021
Q1
$275K Buy
+3,390
New +$271K 0.22% 114

Other funds holding TKR

USA Financial Formulas's TKR Position: Q2 2026 in Review

USA Financial Formulas reduced its Timken Company (TKR) stake by 32% in Q2 2026, selling an estimated $72K and leaving 1,276 shares worth $185K. The position accounts for 0.03% of the portfolio, ranked #144.

USA Financial Formulas first reported a position in TKR in Q1 2021 and has held it in 7 quarters since. The position peaked at $275K in Q1 2021. 605 funds tracked by Wall St. Rank hold TKR as of Q2 2026.

  • USA Financial Formulas held 1,276 shares of Timken Company worth $185K as of Q2 2026.
  • USA Financial Formulas sold 599 Timken Company shares in Q2 2026, an estimated $72K.
  • Timken Company made up 0.03% of USA Financial Formulas's portfolio in Q2 2026, its #144 holding.
  • USA Financial Formulas first reported a position in Timken Company in Q1 2021 and has held it in 7 quarters since.
  • USA Financial Formulas's Timken Company position peaked at $275K in Q1 2021.
  • 605 funds tracked by Wall St. Rank held Timken Company as of Q2 2026.

Based on USA Financial Formulas's 13F filing for Q2 2026, filed 4 Aug 2026.